Nebuhaler - Effective delivery of inhaled budesonide to pre-school children with asthma

Budesonide delivered via Nebuhaler to pre-school children provided effective control of asthma symptoms.

1.	Gleeson JGA, et al. BMJ 1988; 297: 163–6

2.	Bisgaard H, et al. Lancet 1990; 336: 649–51

3.	Connett GJ, et al. Arch Dis Child 1993; 69: 351–55

4.	Noble V, et al. Arch Dis Child 1992; 67: 285–8

1. Gleeson JGA, et al. BMJ 1988; 297: 163–6

Budesonide via Nebuhaler provided effective prophylaxis of asthma in patients aged 2–6 years with poorly-controlled asthma. Mean morning and evening PEF were significantly (p = 0.004) improved compared with placebo.

Budesonide via Nebuhaler improves morning and evening PEF compared with placebo

Adapted from Gleeson et al., 1988.

2. Bisgaard H, et al. Lancet 1990; 336: 649–51

Budesonide pMDI with Nebuhaler gives significant symptom relief and reduces the need for oral prednisolone compared with placebo in young children, aged 11–36 months, with recurrent wheezing.

3. Connett GJ, et al. Arch Dis Child 1993; 69: 351–55

Children, aged 1–3 years, with severe asthma had their daytime and night-time asthma symptoms significantly reduced by the use of inhaled budesonide pMDI via Nebuhaler compared with placebo.

4. Noble V, et al. Arch Dis Child 1992; 67: 285–8

Infants, aged under 18 months, with chronic wheeze experienced significant reduction in symptoms using budesinode pMDI via Nebuhaler compared with placebo.

back to top